Celularity Class A financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

셀룰러리티NASDAQ:CELU · Nasdaq · Healthcare

$1.60+15.94%

2026-10-02 close

Celularity Class A's published financial data is dated 2026-10-04. 2024 revenue was $54M. 2024 operating profit was −$42M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy